Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...

For more information about Stargaze, visit www.stargazestage.com.

Discover how a pioneering program is revolutionizing access to preventative care and empowering advisors to deepen client ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Large-scale ...

Hogan Lovells’ Russell Hedman and Adrienne Ellman say two Delaware Chancery Court decisions signal the need for a strategic ...

ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, ...

CoinDesk Indices is proud to announce the launch of the CoinDesk 80 Index, designed to track the performance of the next 80 ...

Goalsetter was founded by former Nickelodeon and Discovery Education children's digital programming executive Tanya Van Court. For more about Goalsetter visit www.goalsetter.co.

This session will feature Founder and CEO of Goalsetter Tanya Van Court, Edward Jones Advisor Nolan Jeter, and will be moderated by Director of Financial Literacy for University of Phoenix Chris ...

Bank of America Corp. Dep. Pfd. (Rep. 1/1000th 5.875% Non-Cum. Perp. Pfd. Series HH) 1.56% Bank of America Corp. Dep. Pfd. (Rep. 1/1000th Interest in a share of Pfd. Series E) 0.65% Bank of ...

Discover Financial Services Trading Up 3.7 % Shares of NYSE DFS opened at $187.49 on Thursday. The firm has a market capitalization of $47.12 billion, a PE ratio of 15.13, a PEG ratio of 1.12 and ...